SCHEMBL7326987

SCHEMBL7326987

COc1cccc2cc(C(=O)Nc3ccc(-n4nc(C(F)(F)F)cc4C(F)(F)F)cc3)oc12

nearest known ligand 0.62

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.62
TP53 P04637 4/20 0.62
THRB P10828 3/20 0.56
ORAI1 Q96D31 3/20 0.53
TRPC3 Q13507 2/20 0.53
TRPC5 Q9UL62 1/20 0.53
KDM4E B2RXH2 2/20 0.53
PTGDR2 Q9Y5Y4 1/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
TRPC1 P48995 1/20 0.49
STIM1 Q13586 1/20 0.49
MMP2 P08253 1/20 0.49
MMP14 P50281 1/20 0.49
LMNA P02545 1/20 0.47
RECQL P46063 1/20 0.47
POLB P06746 1/20 0.47
CHRNA7 P36544 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7324914 0.82 MAPT (0.67) MAPTTP53THRBORAI1TRPC3
SCHEMBL7316257 0.82 ORAI1 (0.59) MAPTTP53ORAI1TRPC3TRPC5
SCHEMBL7327001 0.81 MAPT (0.61) MAPTTP53THRBORAI1TRPC3
SCHEMBL7323958 0.81 MAPT (0.87) MAPTTP53THRBORAI1TRPC3
SCHEMBL24583862 0.77 MAPT (0.51) MAPTTP53KDM4EPTGDR2SMN1; SMN2
SCHEMBL7323633 0.77 MAPT (0.71) MAPTTP53THRBORAI1TRPC3
SCHEMBL7321362 0.76 THRB (0.87) MAPTTP53THRBORAI1TRPC3
SCHEMBL6837523 0.76 MAPT (0.67) MAPTTP53KDM4EPTGDR2SMN1; SMN2
SCHEMBL6833294 0.76 RAB9A (0.66) MAPTTP53KDM4EPTGDR2SMN1; SMN2
SCHEMBL7316497 0.76 ORAI1 (0.63) MAPTTP53THRBORAI1TRPC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES 2001-11-22 US claimed
EP-1068187-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 2001-01-17 EP claimed
WO-1999051580-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 1999-10-14 WO claimed
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES 2001-11-22 US disclosed
EP-1068187-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 2001-01-17 EP disclosed
WO-1999051580-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 1999-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION IL5, IL2, IL4 MAPT 2674/4885TP53 1903/4885THRB 3730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.